Results 251 to 260 of about 47,533 (300)

Correction: THBS2 + cancer-associated fibroblasts promote EMT leading to oxaliplatin resistance via COL8A1-mediated PI3K/AKT activation in colorectal cancer. [PDF]

Mol Cancer
Zhou X, Han J, Zuo A, Ba Y, Liu S, Xu H, Zhang Y, Weng S, Zhou Z, Liu L, Luo P, Cheng Q, Zhang C, Chen Y, Shan D, Liu B, Yang S, Han X, Deng J, Liu Z.   +19 more
europepmc   +1 more source

Targeting the <i>ZMYM2-ANXA9</i> Axis with <i>FLT3</i> Inhibitor G749 Overcomes Oxaliplatin Resistance in Colorectal Cancer. [PDF]

Biomedicines
Lin D, Xu Y, Zhan H, Liang Y, Liu R, Liu J, Luo D, Chen X, Cai J, Zou Y.   +9 more
europepmc   +1 more source

LncRNA NORAD Promotes Oxaliplatin Resistance in Adenocarcinoma of Esophagogastric Junction via Sponging miR-433-3p and Activating Autophagy [PDF]

Huabing Ma, Jing Wang, Jiaxin Liu, Hui Li, Xiaomin Zhang, Yanchao Chen, Yanxin Gong, Ruying Hu, Yong Zhang, Shoumiao Li   +9 more
openalex   +1 more source

CRCs-CAFs crosstalk-targeted nano-delivery system reprograms tumor microenvironment for oxaliplatin resistance reversing and liver metastasis inhibition in colorectal cancer. [PDF]

Bioact Mater
Liu H, Xu C, Wang P, Guo L, Yan X, Zhou R, Tang Y, Wang S, Chen J, Wang Q, Tian H.   +10 more
europepmc   +1 more source

Mechanical forces inducing oxaliplatin resistance in pancreatic cancer can be targeted by autophagy inhibition. [PDF]

Commun Biol
Kalli M, Mpekris F, Charalambous A, Michael C, Stylianou C, Voutouri C, Hadjigeorgiou AG, Papoui A, Martin JD, Stylianopoulos T.   +9 more
europepmc   +1 more source

Additional file 10 of Multi-omics analysis of patient-derived organoids reveals that E3 ligase COP1 promotes liver metastasis and oxaliplatin resistance in colorectal cancer through LUZP1 degradation and MYL9 phosphorylation

Ruijia Zhang, Wenqin Luo, Qikai Zhou, Dongguo Liang, Yuankai Hao, F Chen, Yulin Qiu, Yixian Cao, Zezhi Shan, Yu Zhang, Qingguo Li, Sanjun Cai, Dakui Luo, Shaobo Mo, Bin Ma, Xinxiang Li   +15 more
openalex   +1 more source

Investigating the role of NEIL3 in colorectal cancer resistance to oxaliplatin

Colorectal cancer (CRC) is the third most common type of cancer and accounts for 8 % of cancer related deaths worldwide. While the likelihood of colorectal carcinogenesis increases with age, genetics and lifestyle are major predisposing factors. Treatment can be curative and promises a 39 – 65% survival rate depending on the stage at cancer diagnosis ...
openaire  

ALYREF-Mediated Regulation of TBL1XR1 and KMT2E Synergistically Upregulates APOC1, Contributing to Oxaliplatin Resistance in Esophageal Cancer. [PDF]

Cancer Res Treat
Hu J, Liu Q, Feng B, Lu Y, Chen K.
europepmc   +1 more source

The expression of exosomal and cellular miRNAs in predicting oxaliplatin resistance in colorectal cancer cells: an in silico and in vitro study. [PDF]

BMC Cancer
Deli H, Vakili-Ghartavol Z, Asgari Y, Tavoosidana G, Eftekhar E, Ghahremani MH.   +5 more
europepmc   +1 more source

MRP2 as a Targetable Oxaliplatin Resistance Factor in Gastrointestinal Cancer

, 2018
Riya Biswas
openalex   +1 more source